Cardinal Health Inc
Cardinal Health Inc (CAH) Covered Calls
Cardinal Health Inc trades in the Medical Distribution industry with an IV Rank of 35.32%, average versus the past year. CAH's highest covered call setup is the $305.00 strike expiring Nov 20, 2026, sorted by theoretical annualized return. It's 7.45% out of the money with 4 days to expiration, a 7.47% return until expiration, and a 681.52% theoretical annualized return. Across the setups shown, annualized returns run from 165.41% to 681.52% at strikes between $287.50 and $310.00, with 4 to 18 days to expiration, as of Nov 16, 2026.
Read more
Running CAH covered calls helps you generate income from Cardinal Health Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CAH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call pairs limited risk with a clear income profile. If CAH stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CAH covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CAH covered call is worth writing.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals.
| 2026-11-20 | 4 | 305.00 | 7.45 | 0.05 | 2.10 | 2120.00 | 7.47 | 681.52 | -0.02 | +0.13 | 0 | 2.05 |
| 2026-11-20 | 4 | 300.00 | 5.69 | 0.20 | 0.40 | 1635.00 | 5.76 | 525.61 | -0.07 | +0.07 | 19 | 0.20 |
| 2026-11-20 | 4 | 297.50 | 4.81 | 0.35 | 2.00 | 1400.00 | 4.93 | 450.06 | -0.12 | +0.17 | 0 | 1.65 |
| 2026-11-20 | 4 | 295.00 | 3.93 | 0.30 | 0.90 | 1145.00 | 4.03 | 368.09 | -0.11 | +0.13 | 16 | 0.60 |
| 2026-11-20 | 4 | 292.50 | 3.05 | 0.70 | 2.80 | 935.00 | 3.29 | 300.58 | -0.25 | +0.25 | 1 | 2.10 |
| 2026-11-27 | 11 | 305.00 | 7.45 | 0.10 | 0.60 | 2125.00 | 7.49 | 248.41 | -0.04 | +0.06 | 4 | 0.50 |
| 2026-11-20 | 4 | 290.00 | 2.17 | 1.15 | 2.95 | 730.00 | 2.57 | 234.68 | -0.41 | +0.30 | 43 | 1.80 |
| 2026-12-04 | 18 | 310.00 | 9.21 | 0.05 | 2.90 | 2620.00 | 9.23 | 187.17 | -0.02 | +0.14 | 0 | 2.85 |
| 2026-11-20 | 4 | 287.50 | 1.29 | 1.85 | 2.60 | 550.00 | 1.94 | 176.81 | -0.65 | +0.36 | 11 | 0.75 |
| 2026-11-27 | 11 | 297.50 | 4.81 | 0.50 | 1.45 | 1415.00 | 4.99 | 165.41 | -0.18 | +0.15 | 0 | 0.95 |
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryMedical Distribution
- SectorHealthcare
- IV Rank35.32% Moderate
- Market cap (M$)64,545
- 52 weeks high-2.46%
- 52 weeks low54.75%
- Analyst recommendationBuy
1.57 - Target price$302.47
8.32% above the current stock price - Dividend—
- Payout ratio28.32%
- Earnings date2027-02-04
- P/E36.11
- Future P/E19.40
- EPS (ttm)7.73
- EPS growth next 5 years12.35%
As of Nov 16, 2026